Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C

Digestive Diseases and Sciences

Volumn 41, Issue 12, 1996, Pages 2453-2458

  Okazaki, Muneko ^a,b   Hino, Keisuke ^a   Fujii, Kaori ^a   Kobayashi, Nobuyuki ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

chronic hepatitis C; Fas antigen; immunohistology; interferon therapy

Indexed keywords

FAS ANTIGEN; INTERFERON;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LIVER BIOPSY; MALE; PRIORITY JOURNAL;

EID: 0030470528     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02100142     Document Type: Article

References (28)

1. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991
2. Nagata S: Fas and Fas ligand: A death factor and its receptor. Adv Immunol 57:129-144, 1994
3. Anel A, Buferne M, Boyer C, Schmit-Verhulst A-M, Golstein P: T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 24:2469-2476, 1994
4. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, 1993
5. Searle J, Harmon BV, Bishop CJ, Kerr JFR: The significance of cell death by apoptosis in hepatobiliary disease. J Gastroenterol Hepatol 2:77-96, 1987
6. Schupper H, Hayashi P, Scheffel J, Aceituno S. Paglieroni T, Holland PV, Zeldis JB: Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology 18:1055-1060, 1993
7. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD: Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339-3344, 1992
8. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T: Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354-1359, 1994
9. Yousuf M, Nakano Y, Tanaka E, Sodeyama T, Kiyosawa K: Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up. Scand J Gastroenterol 27:812-816, 1992
10. Desmet VJ, Gerber M, Hoofnagel JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading, and staging. Hepatology 19:1513-1520, 1994
11. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal Biochem 162:156-159, 1987
12. Kanai K, Iwata K, Nakao M, Okamoto H: Suppression of hepatitis C virus RNA by interferon a. Lancet 336:245, 1990
13. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M: Detection of hepatitis C virus by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 60:215-222, 1990
14. Kwok S, Higuchi R: Avoiding false positives with PCR. Nature 339:237-238, 1989
15. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679, 1992
16. Hino K, Okuda M, Konishi T, Ishiko H, Okita K: Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α. Dig Dis Sci 40:14-20, 1995
17. Koji T, Kobayashi N, Nakanishi Y, Yoshii A, Hashimoto S, Shibata Y, Anjiki N, Yamamoto R, Aoki A, Ueda T, Kanazawa S, Nakane PK: Immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides. Acta Histochem Cytochem 27:459-463, 1994
18. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391-2399, 1993
19. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Bisgeglie AD, Peters M, Waggoner JG, Park Y, Jones EA: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon; A preliminary report. N Engl J Med 315:1575-1578, 1986
20. Lowin B, Hahne M, Maltmann C, Tschoop J: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650-652, 1994
21. Cohen JJ, Duke CD, Fadok VA, Sellines KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267-293, 1992
22. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305, 1989
23. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 87:9620-9624, 1990
24. Falk MH, Trauth BC, Debatin KM, Klas C, Gregory CD, Rickinson AB, Calender A, Lenoir GM, Ellwart JW, Krammer PH, Bornkamm GW: Expression of APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79:3300-3306, 1992
25. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756, 1989
26. Owen-Schaub LB, Yonehara S, Crump III WL, Grimm EA: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197-205, 1992
27. Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kasahara A, Fusamoto H, Kamada T: Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Comm 204:468-474, 1994
28. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14:1129-1135, 1995